Genedrive added that "it did not receive any expressions of interest from potential acquirers". The firm said the placing extends its cash runway through to the end of 2025. However, should the ...
Both firms are UK-based student accommodation providers. The acquisition was approved at a court and general meeting on Monday. Just under 71% of votes in the court meeting gave the deal the green ...
For the third quarter of 2025, Mondi said its underlying earnings before interest, taxes, depreciation and amortisation fell 19% to EUR223 million from EUR274 million in the second quarter, but was ...
In European equities on Monday, the CAC 40 in Paris closed down 1.4%, while the DAX 40 in Frankfurt ended unchanged. The CAC 40 tumbled after Prime Minister Sebastien Lecornu resigned.
On Monday last week, Beacon Rise said entered non-binding heads of terms to acquire Ergotec for approximately GBP1.0 million. At this time, Beacon Rise said it was preliminary discussions with regard ...
Aeorema Communications PLC - London-based live events agency - Aeorema's Cheerful Twentyfirst brand experience agency has seen "consistent and continued momentum" in North America over the past three ...
(Alliance News) - Ananda Pharma PLC on Monday said the last patient has received their final MRX1 dose in the phase one pharmacokinetic study. Ananda is a London-based biopharmaceutical company that ...
The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: SkinBioTherapeutics PLC - life science firm focused on skin health - ...
Finance News; tinyBuild says will meet full-year outlook but notes Kingmakers delay; tinyBuild says will meet full-year outlook but notes Kingmakers delay ...
Finance News; Tap Global hails "landmark" digital banking partnership with Moorwand; Tap Global hails "landmark" digital banking partnership with Moorwand ...
Fulcrum has been issued with 78.7 million common shares in Loyalist, as well as CAD500,000 in cash, which is about GBP266,344, and a 2.0% net smelter return royalty on the Tully project.
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results